Vivani Medical, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
VANI Nasdaq 3840 www.vivani.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vivani Medical, Inc.

Vivani Medical Insiders Added US$5.29m Of Stock To Their Holdings - Jun 30th, 2025 12:50 pm
Vivani Medical Appoints Anthony Baldor as Chief Financial Officer - Jun 11th, 2025 6:00 am
Vivani Medical to Present at the 2025 BIO International Convention - Jun 10th, 2025 6:30 am
Vivani Stock Gains After Announcing Spin-Off Plans for Cortigent Unit - Jun 2nd, 2025 6:38 am
Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders - May 29th, 2025 6:30 am
Vivani Medical: Q1 Earnings Snapshot - May 13th, 2025 2:36 pm
Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results - May 13th, 2025 2:30 pm
Vivani Medical to Present at the American Association of Pharmaceutical Scientists’ “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop - May 7th, 2025 6:30 am
Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company - Apr 16th, 2025 6:30 am
Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity - Apr 15th, 2025 6:30 am
EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs - Apr 15th, 2025 6:03 am
April 2025's Top Penny Stocks To Watch - Apr 10th, 2025 12:05 pm
Vivani Medical: Q4 Earnings Snapshot - Mar 31st, 2025 5:50 am
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results - Mar 31st, 2025 5:30 am
Vivani Medical Announces $8.25M Private Placement Equity Financing - Mar 27th, 2025 5:32 am
Vivani Medical Gives Data for Weight Loss Implant - Mar 26th, 2025 12:51 pm
Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing - Mar 26th, 2025 5:30 am
EXCLUSIVE: Vivani Medical Subdermal Semaglutide Implant Shows 20% Weight Loss In Animal Study, With Potential For Once-Yearly Dosing - Mar 26th, 2025 5:00 am
Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now - Mar 26th, 2025 5:00 am
Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025 - Mar 24th, 2025 6:30 am